Pancreatic cancer is among the hardest to treat and deserves honest conversation. In Japan, heavy ion therapy is evaluated as a local-control option, and incision-free catheter therapies (IGT) as supportive approaches in advanced disease.
For locally advanced, inoperable cases, heavy ion therapy is practiced at Japanese centers.
Regional catheter-based therapies and hyperthermia are incision-free supportive options.
Personalized vaccine (AFTV) may be considered in addition to standard care in suitable cases.
No general 'success rate' can be quoted for pancreatic cancer; stage, performance status and prior treatments determine outcomes.